circulating tumor DNA Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Aug 2, 2022 Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer Jul 22, 2022 Lung Cancer MRD Study Bolsters Validity Evidence, Suggests Longitudinal Test Cutoff Premium Jul 8, 2022 BillionToOne, UCSD Partner to Assess New Liquid Biopsy Assays in Lung Cancer Jul 7, 2022 ESMO Releases Guidelines for Liquid Biopsy Testing in Cancer Patients Jun 8, 2022 New Data Suggests Liquid Biopsy Provides Early ID of Breast Cancer Patients Destined to Recur Premium Jun 7, 2022 Circulating Tumor DNA Utility in Post-Surgery Stage II Colon Cancer Cemented by New Data Premium Jun 3, 2022 Genetron Highlights New Minimal Residual Disease Data, Sets Plans for Solid Tumor Testing in China Premium May 9, 2022 Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal May 9, 2022 Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism Premium May 6, 2022 Personalis Building Data for High-Sensitivity Residual Cancer Assay Premium Apr 13, 2022 Guardant Health, Exact Sciences Make Progress on Multi-Cancer Detection Tests Premium Apr 12, 2022 C2i Genomics Lays Groundwork for Global Launch of Whole-Genome Minimal Residual Disease Test Premium Mar 9, 2022 Natera Minimal Residual Disease Test Value Called Into Question by City of Hope CRC Patient Data Feb 17, 2022 New Data Further Validates Inivata's MRD Test as Company Prepares Commercial Launch Premium Dec 17, 2021 Genecast Minimal Residual Disease Test Plans Bolstered by New Lung Cancer Data Premium Nov 4, 2021 Guardant Health Q3 Revenues Up 27 Percent Oct 15, 2021 Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions Premium Sep 21, 2021 Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy Sep 15, 2021 Molecular Health, Eone-Diagnomics Genome Center Ink Liquid Biopsy Partnership Load More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
